EXHIBIT 11.1 SONUS PHARMACEUTICALS, INC. COMPUTATION OF NET INCOME (LOSS) PER SHARE
Three Months Ended Nine Months Ended September 30, September 30, ----------------------------- ------------------------------- 1996 1995 1996 1995 ---------- ----------- ----------- ----------- Net income (loss) .............................. $2,801,745 $(1,947,175) $ (925,037) $(2,838,157) ========== =========== =========== =========== Weighted average shares outstanding ............ 8,490,201 1,952,864 8,467,100 1,963,843 Net effect of stock option exercised and stock options and warrants granted during the 12 months prior to the Company's filing of its initial public offering, calculated using the treasury stock method at the offering price of $7 per share, and treated as outstanding for all periods prior to the closing of the initial public offering ...................... -- 97,196 -- 97,730 Net effect of common stock equivalents calculated using the treasury stock method ... 640,790 -- -- -- ---------- ----------- ----------- ----------- Shares used in computation of net income (loss) per share ............................. 9,130,992 2,050,060 8,467,100 2,061,573 ========== =========== =========== =========== Net income (loss) per share .................... $ 0.31 $ (0.95) $ (0.11) $ (1.38) ========== =========== =========== ===========
12